NEXGEL expects pro forma annual revenue of roughly $35M following Celularity wound segment acquisition
NexGel, Inc Common Stock · Now $0.59
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS